Scientific Plant and Technology based companies held a conference, where AXEB had the pleasure of participating as a speaker. The presentation of our company deals with the latest developments in biostimulants and latest research and news that the company is carrying out.
AXEB Biotech is involved in R&D to give solution to agricultural community to improve plant health and enhance crop yield and conditioning of soil by the use of innovative biostimulants, plant nutrition products, specialized fertilizers and adjuvants.
More than 60 researchers and companies in the nutrition and plant protection participated at the \”Plant Companies and Scientific Technology based\” organized by the Biovegen platform. BIOVEGEN is a public-private partnership, led by the business sector, which brings together entities from the agrifood sector with an interest in R&D&i in applied Plant Biology. Made up of companies from the agrifood sector:
- Plant breeders: intensive and extensive crops
- Fertilizers, plant nutrition
- Plant protection
- Agrobiotechnology and R&D&I management
- Public Research Organisations
- Administration
BIOVEGEN\’s objetive is to improve the Spanish agrifood sector competitiveness through the incorporation of new technologies based on Plant Biology:
- Development of R&D collaborative projects
- Foster knowledge and technology transfer towards the Industry
- Contribute to the design of R&D strategies adapted to the Agrifood sector
- Promote greater public and private investment in R&D
The Conference, held in Barcelona, pretended to bring together scientists from plants and companies in plant nutrition and protection to develop agreements and collaboration opportunities. For that, the speech of Axeb about on innovations in plant nutrition products developed by the company. Ricard Casals, the manager of the company, and Ruben Torregrosa, Ph. D Food Science and AXEB R&D Project Manager, represented our company.
If you want to know all the projects that AXEB is doing nowadays, as well as the ones it has done previously, visit the following link to our R&D trajectory.
